785 related articles for article (PubMed ID: 36558421)
1. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.
Fitriakusumah Y; Lesmana CRA; Bastian WP; Jasirwan COM; Hasan I; Simadibrata M; Kurniawan J; Sulaiman AS; Gani RA
BMC Gastroenterol; 2019 Mar; 19(1):43. PubMed ID: 30894137
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study.
Gkolfakis P; Tziatzios G; Leite G; Papanikolaou IS; Xirouchakis E; Panayiotides IG; Karageorgos A; Millan MJ; Mathur R; Weitsman S; Dimitriadis GD; Giamarellos-Bourboulis EJ; Pimentel M; Triantafyllou K
Microorganisms; 2023 Mar; 11(3):. PubMed ID: 36985296
[TBL] [Abstract][Full Text] [Related]
5. Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth.
Rafiei R; Bemanian M; Rafiei F; Bahrami M; Fooladi L; Ebrahimi G; Hemmat A; Torabi Z
Rom J Intern Med; 2018 Jun; 56(2):85-89. PubMed ID: 29101772
[TBL] [Abstract][Full Text] [Related]
6. PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS.
GuimarÃes VM; Santos VN; Borges PSA; DE Farias JLR; Grillo P; Parise ER
Arq Gastroenterol; 2020; 57(4):471-476. PubMed ID: 33331479
[TBL] [Abstract][Full Text] [Related]
7. Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy.
Mikolasevic I; Delija B; Mijic A; Stevanovic T; Skenderevic N; Sosa I; Krznaric-Zrnic I; Abram M; Krznaric Z; Domislovic V; Filipec Kanizaj T; Radic-Kristo D; Cubranic A; Grubesic A; Nakov R; Skrobonja I; Stimac D; Hauser G
Int J Clin Pract; 2021 Apr; 75(4):e13947. PubMed ID: 33406286
[TBL] [Abstract][Full Text] [Related]
8. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Wijarnpreecha K; Lou S; Watthanasuntorn K; Kroner PT; Cheungpasitporn W; Lukens FJ; Pungpapong S; Keaveny AP; Ungprasert P
Eur J Gastroenterol Hepatol; 2020 May; 32(5):601-608. PubMed ID: 31567712
[TBL] [Abstract][Full Text] [Related]
9. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.
Belei O; Olariu L; Dobrescu A; Marcovici T; Marginean O
J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1161-1168. PubMed ID: 28988228
[TBL] [Abstract][Full Text] [Related]
10. Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis.
Kuang L; Zhou W; Jiang Y
PLoS One; 2021; 16(12):e0260479. PubMed ID: 34855819
[TBL] [Abstract][Full Text] [Related]
11. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.
Gandhi A; Shah A; Jones MP; Koloski N; Talley NJ; Morrison M; Holtmann G
Gut Microbes; 2021; 13(1):1933313. PubMed ID: 34190027
[TBL] [Abstract][Full Text] [Related]
12. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis.
Feng X; Li XQ; Jiang Z
Clin Rheumatol; 2021 Aug; 40(8):3039-3051. PubMed ID: 33426631
[TBL] [Abstract][Full Text] [Related]
14. Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
Gudan A; Kozłowska-Petriczko K; Wunsch E; Bodnarczuk T; Stachowska E
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986052
[TBL] [Abstract][Full Text] [Related]
15. Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease.
Fialho A; Fialho A; Thota P; McCullough AJ; Shen B
J Gastrointestin Liver Dis; 2016 Jun; 25(2):159-65. PubMed ID: 27308646
[TBL] [Abstract][Full Text] [Related]
16. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.
Komolafe O; Buzzetti E; Linden A; Best LM; Madden AM; Roberts D; Chase TJ; Fritche D; Freeman SC; Cooper NJ; Sutton AJ; Milne EJ; Wright K; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013157. PubMed ID: 34280304
[TBL] [Abstract][Full Text] [Related]
17. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis.
Balakrishnan M; Patel P; Dunn-Valadez S; Dao C; Khan V; Ali H; El-Serag L; Hernaez R; Sisson A; Thrift AP; Liu Y; El-Serag HB; Kanwal F
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):61-71.e15. PubMed ID: 32360810
[TBL] [Abstract][Full Text] [Related]
18. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F
J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Encephalopathy in Cirrhotic Patients and Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis.
Feng X; Li X; Zhang X; Chen W; Tian Y; Yang Q; Yang Y; Pan H; Jiang Z
Biomed Res Int; 2022; 2022():2469513. PubMed ID: 36303585
[TBL] [Abstract][Full Text] [Related]
20. Association of small intestinal bacterial overgrowth with Parkinson's disease: a systematic review and meta-analysis.
Li X; Feng X; Jiang Z; Jiang Z
Gut Pathog; 2021 Apr; 13(1):25. PubMed ID: 33863370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
